Thalidomide Reduces Arteriovenous Malformation Related Gastrointestinal Bleeding

Clinical trial NCT00389935 · COMPLETED

Trial details

NCT number: NCT00389935
Sponsor: Northport Veterans Affairs Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Arteriovenous Malformation Hereditary Hemorrhagic Telangiectasia Hematochezia Melena

Start date: 2006-10-01
Primary completion: 2011-06-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.